MANE financial statements
The full income statement, balance sheet, and cash-flow statement for Veradermics Incorporated (MANE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 |
|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | |
| 72.3M+170.2% | 26.8M | ||
| Research & development | 62.1M+166.6% | 23.3M | |
| Selling, general & administrative | 10.3M+194.2% | 3.50M | |
| General & administrative | 10.3M+194.2% | 3.50M | |
| Operating income | -72.3M-170.2% | -26.8M | |
| Interest expense | 0.00-100.0% | 585K | |
| Interest & investment income | 1.56M+224.7% | 481K | |
| Other non-operating income | 2.35M+711.0% | 290K | |
| Pre-tax income | -70.0M-164.3% | -26.5M | |
| Income tax | 0.00 | 0.00 | |
| -70.0M-164.3% | -26.5M | ||
| Net income to common | -83.4M-205.4% | -27.3M | |
| -$111.91-202.1% | -$37.05 | ||
| EPS (basic) | -$111.91-202.1% | -$37.05 | |
| Weighted-avg shares (basic) | 745K+1.1% | 737K | |
| Weighted-avg shares (diluted) | 745K+1.1% | 737K | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | |
| 152M+174.6% | 55.5M | ||
| Cash & equivalents | 21.8M-59.0% | 53.1M | |
| Prepaid expenses | 10.6M+333.8% | 2.45M | |
| Other current assets | 307K+707.9% | 38.0K | |
| 153M+174.8% | 55.5M | ||
| Property, plant & equipment | 22.0K | 0.00 | |
| Operating lease right-of-use | 103K | 0.00 | |
| Total non-current assets | 125K | 0.00 | |
| 9.15M+94.0% | 4.72M | ||
| Accounts payable | 2.13M-5.4% | 2.25M | |
| Accrued liabilities | 6.98M+182.6% | 2.47M | |
| Other current liabilities | 47.0K | 0.00 | |
| 9.16M+94.1% | 4.72M | ||
| Non-current lease liability | 4.00K | 0.00 | |
| -121M-149.6% | -48.5M | ||
| Preferred stock | 0.00 | — | |
| Common stock | 1.00K+0.0% | 1.00K | |
| Additional paid-in capital | 2.35M+212.8% | 750K | |
| Retained earnings | -123M-150.7% | -49.2M | |
| Accumulated other comprehensive income | 60.0K | 0.00 | |
| Total liabilities & equity | 153M+174.8% | 55.5M | |
| Common shares issued | 750K+1.7% | 737K | |
| Common shares outstanding | 750K+1.7% | 737K | |
| Shares outstanding (cover) | 37.3M | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | |
| -71.6M-202.3% | -23.7M | ||
| Share-based compensation | 1.44M+476.0% | 250K | |
| Change in payables | -122K-118.9% | 646K | |
| -119M | 0.00 | ||
| Capital expenditure | 24.0K | 0.00 | |
| Free cash flow | -71.6M-202.4% | -23.7M | |
| Acquisitions | 0.00 | 0.00 | |
| 159M+163.1% | 60.5M | ||
| Long-term debt issued | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | |
| Net change in cash | -31.3M-185.1% | 36.8M | |
| Interest paid | 0.00-100.0% | 95.0K | |
| Income taxes paid | 0.00 | 0.00 | |
| Source filing | 10-K | 10-K |
About this data
Source: MANE’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MANE filings on SEC EDGAR → Not investment advice.